Therefore, we adopted the meta-analysis method to comprehensively analyze the existing data in order to provide evidence-based medicine evidence for clarifying the relationship between HLA-DRB1 allele polymorphism and breast cancer genetic susceptibility. Here, HLA-DRB1 is linked to breast cancer.